Issued 2026-09-25 at $24.92 · now $24.92 (2026-09-25, +0.0% since)
Based on its own history, a month from the 2026-09-25 close, TNGX has typically landed between $17.08 and $36.94 — a range of −31.5% to +48.2% from the issuance price $24.92.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
1,500 overlapping 1 month windows · 2020-09-03 – 2026-08-26 · basis climatology · forecast (batch). Base rate up 53.7% (90% CI 51.5–55.9%, ≈1,391 obs). Not a call on this stock — we have no evidence its odds differ.
The cone is anchored at the 2026-09-25 issuance close ($24.92) — the price the forecast resolves against on 2026-10-26, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where TNGX has typically landed a month from the 2026-09-25 close of $24.92 — the range is history, not a prediction.
- now $24.92 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $24.42 (-2.0%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $20.54–$28.31
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $17.08–$36.94
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2024-10-09 | −58.3% | −58.3% | +10.0% |
| 2024-10-10 | −55.0% | −56.8% | +13.9% |
| 2024-10-08 | −53.0% | −53.0% | +8.3% |
| 3 best | |||
| 2025-05-09 | +292.1% | +0.0% | +292.1% |
| 2025-05-08 | +278.2% | +0.0% | +287.3% |
| 2025-05-07 | +270.4% | −4.3% | +270.4% |
1,500 overlapping windows · 2020-09-03 – 2026-09-25 · not cherry-picked
Pending catalysts
- 2027-03-31 — Trial primary completion: Phase 1/Phase PHASE2 primary completion: Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss (source, as of 2026-08-14)
- June 2027 — Trial primary completion: Phase 1/Phase PHASE2 primary completion: Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients (source, as of 2026-08-14)
Public, scheduled events — dated attention, not a prediction of the outcome. See the FDA catalysts page for the historical base rate.
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~6 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-22 | Newcomb Jessica | officer | Sale | 5,100 @ $23.97 | $122K | −7.7% of holding | not yet — horizon still open | not yet — horizon still open | 61,521 | Form 4 · filed 2 days after the trade |
| 2026-09-22 | Newcomb Jessica | officer | Sale | 2,400 @ $25.17 | $60K | −3.9% of holding | not yet — horizon still open | not yet — horizon still open | 59,121 | Form 4 · filed 2 days after the trade |
| 2026-09-22 | Newcomb Jessica | officer | Sale | 700 @ $22.80 | $16K | −1.0% of holding | not yet — horizon still open | not yet — horizon still open | 66,621 | Form 4 · filed 2 days after the trade |
| 2026-09-01 | Crystal Adam | officer | Sale | 27,000 @ $22.37 | $604K | −18.9% of holding | not yet — horizon still open | not yet — horizon still open | 115,743 | Form 4 · filed 2 days after the trade |
| 2026-08-03 | Crystal Adam | officer | Sale | 21,733 @ $27.35 | $594K | −15.8% of holding | −18.4% | not yet — horizon still open | 115,743 | Form 4 · filed 2 days after the trade |
| 2026-08-03 | Crystal Adam | officer | Sale | 5,267 @ $26.79 | $141K | −3.7% of holding | −18.4% | not yet — horizon still open | 137,476 | Form 4 · filed 2 days after the trade |
| 2026-07-01 | Crystal Adam | officer | Sale | 19,629 @ $29.34 | $576K | −13.8% of holding | −5.6% | not yet — horizon still open | 123,114 | Form 4 · filed 1 day after the trade |
| 2026-07-01 | Crystal Adam | officer | Sale | 7,371 @ $30.25 | $223K | −6.0% of holding | −5.6% | not yet — horizon still open | 115,743 | Form 4 · filed 1 day after the trade |
| 2026-06-01 | Crystal Adam | officer | Sale | 20,860 @ $23.06 | $481K | −15.3% of holding | +25.8% | not yet — horizon still open | 115,743 | Form 4 · filed 2 days after the trade |
| 2026-06-01 | Crystal Adam | officer | Sale | 6,140 @ $22.25 | $137K | −4.3% of holding | +25.8% | not yet — horizon still open | 136,603 | Form 4 · filed 2 days after the trade |
| 2026-05-01 | Crystal Adam | officer | Sale | 25,900 @ $21.19 | $549K | −18.1% of holding | −2.9% | not yet — horizon still open | 116,843 | Form 4 · filed 4 days after the trade |
| 2026-05-01 | Crystal Adam | officer | Sale | 1,100 @ $22.00 | $24K | −0.9% of holding | −2.9% | not yet — horizon still open | 115,743 | Form 4 · filed 4 days after the trade |
| 2026-04-15 | Crystal Adam | officer | Sale | 38,460 @ $25.00 | $962K | −25.5% of holding | −8.7% | not yet — horizon still open | 112,622 | Form 4 · filed 1 day after the trade |
| 2026-04-01 | Crystal Adam | officer | Sale | 27,000 @ $21.20 | $572K | −19.3% of holding | −11.1% | not yet — horizon still open | 112,622 | Form 4 · filed 1 day after the trade |
| 2026-03-25 | Crystal Adam | officer | Sale | 12,000 @ $20.11 | $241K | −9.6% of holding | +14.7% | +0.9% | 112,622 | Form 4 · filed 2 days after the trade |
| 2026-03-05 | Crystal Adam | officer | Sale | 20,251 @ $15.00 | $304K | −15.2% of holding | +23.6% | +21.2% | 112,622 | Form 4 · filed 4 days after the trade |
| 2026-02-25 | Crystal Adam | officer | Sale | 54,345 @ $12.77 | $694K | −29.0% of holding | +63.9% | +90.6% | 132,873 | Form 4 · filed 2 days after the trade |
| 2026-02-03 | Weber Barbara | director | Sale | 30,186 @ $12.26 | $370K | −1.8% of holding | +35.3% | +117.2% | 1,629,587 | Form 4 · filed 1 day after the trade |
| 2026-02-03 | Crystal Adam | officer | Sale | 18,251 @ $12.26 | $224K | −8.9% of holding | +35.3% | +117.2% | 187,419 | Form 4 · filed 1 day after the trade |
| 2026-02-03 | Beckman Daniella | director | Sale | 10,204 @ $12.26 | $125K | −5.2% of holding | +35.3% | +117.2% | 184,410 | Form 4 · filed 1 day after the trade |
| 2026-02-03 | Weber Barbara | director | Sale | 333 @ $12.90 | $4K | −0.0% of holding | +35.3% | +117.2% | 1,629,254 | Form 4 · filed 1 day after the trade |
| 2026-02-03 | Crystal Adam | officer | Sale | 201 @ $12.90 | $3K | −0.1% of holding | +35.3% | +117.2% | 187,218 | Form 4 · filed 1 day after the trade |
| 2026-02-03 | Beckman Daniella | director | Sale | 113 @ $12.90 | $1K | −0.1% of holding | +35.3% | +117.2% | 184,297 | Form 4 · filed 1 day after the trade |
| 2025-10-23 | Third Rock Ventures IV, L.P. | tenPercentOwner | Sale | 477,401 @ $10.15 | $4.8M | −3.4% of holding | +35.1% | +242.6% | 13,386,574 | Form 4 · filed 4 days after the trade |
| 2025-09-16 | Third Rock Ventures IV, L.P. | tenPercentOwner | Sale | 363,541 @ $7.04 | $2.6M | −2.5% of holding | +28.5% | +153.4% | 14,363,975 | Form 4 · filed 1 day after the trade |
| 2025-09-08 | Third Rock Ventures IV, L.P. | tenPercentOwner | Sale | 86,459 @ $7.04 | $609K | −0.6% of holding | +3.6% | +137.3% | 14,727,516 | Form 4 · filed 1 day after the trade |
| 2025-09-05 | Third Rock Ventures IV, L.P. | tenPercentOwner | Sale | 642,906 @ $7.00 | $4.5M | −4.2% of holding | +5.2% | +131.6% | 14,813,975 | Form 4 · filed 4 days after the trade |
| 2025-08-22 | Third Rock Ventures IV, L.P. | tenPercentOwner | Sale | 302,194 @ $7.00 | $2.1M | −1.9% of holding | +2.4% | +79.5% | 15,456,881 | Form 4 · filed 4 days after the trade |
| 2025-08-19 | Third Rock Ventures IV, L.P. | tenPercentOwner | Sale | 1,100,000 @ $7.01 | $7.7M | −6.5% of holding | +9.6% | +69.8% | 15,759,075 | Form 4 · filed 2 days after the trade |
| 2025-02-05 | Weber Barbara | director | Sale | 9,013 @ $3.16 | $28K | −0.6% of holding | −35.3% | +92.0% | 1,622,251 | Form 4 · filed 1 day after the trade |
| 2025-02-05 | Crystal Adam | officer | Sale | 6,851 @ $3.16 | $22K | −4.2% of holding | −35.3% | +92.0% | 158,210 | Form 4 · filed 1 day after the trade |
| 2025-02-05 | Beckman Daniella | director | Sale | 3,948 @ $3.16 | $12K | −2.6% of holding | −35.3% | +92.0% | 150,284 | Form 4 · filed 1 day after the trade |
| 2025-02-05 | Barry Douglas | officer | Sale | 2,556 @ $3.16 | $8K | −3.7% of holding | −35.3% | +92.0% | 66,014 | Form 4 · filed 1 day after the trade |
| 2025-02-04 | Weber Barbara | director | Sale | 9,778 @ $2.99 | $29K | −0.6% of holding | −25.8% | +108.0% | 1,631,264 | Form 4 · filed 2 days after the trade |
| 2025-02-04 | Crystal Adam | officer | Sale | 7,432 @ $2.99 | $22K | −4.3% of holding | −25.8% | +108.0% | 165,061 | Form 4 · filed 2 days after the trade |
| 2025-02-04 | Beckman Daniella | director | Sale | 4,284 @ $2.99 | $13K | −2.7% of holding | −25.8% | +108.0% | 154,232 | Form 4 · filed 2 days after the trade |
| 2025-02-04 | Barry Douglas | officer | Sale | 2,774 @ $2.99 | $8K | −3.9% of holding | −25.8% | +108.0% | 68,570 | Form 4 · filed 2 days after the trade |
| 2024-11-18 | Rothenberg Mace | director | Purchase | 10,000 @ $3.78 | $38K | +47.1% of holding | −22.2% | −47.8% | 31,250 | Form 4 · filed same day |
| 2024-11-14 | Rothenberg Mace | director | Purchase | 10,000 @ $3.62 | $36K | +88.9% of holding | −27.0% | −47.7% | 21,250 | Form 4 · filed 4 days after the trade |
| 2024-11-07 | EcoR1 Capital, LLC | director | Sale | 1,143,124 @ $2.92 | $3.3M | −9.7% of holding | +11.9% | −49.7% | 10,630,736 | Form 4 · filed 1 day after the trade |
| 2024-11-07 | EcoR1 Capital, LLC | director | Sale | 62,318 @ $3.29 | $205K | −0.5% of holding | +11.9% | −49.7% | 11,773,860 | Form 4 · filed 1 day after the trade |
| 2024-11-06 | Boxer Capital Management, LLC | other | Sale | 3,080,000 @ $3.14 | $9.7M | −46.0% of holding | +1.8% | −58.8% | 3,610,642 | Form 4 · filed 1 day after the trade |
| 2024-11-06 | EcoR1 Capital, LLC | director | Sale | 1,494,558 @ $3.28 | $4.9M | −11.2% of holding | +1.8% | −58.8% | 11,836,178 | Form 4 · filed 2 days after the trade |
| 2024-10-25 | Boxer Capital Management, LLC | other | Sale | 633,000 @ $6.87 | $4.3M | −8.6% of holding | −39.1% | −72.6% | 6,690,642 | Form 4 · filed 3 days after the trade |
| 2024-10-22 | Boxer Capital Management, LLC | other | Sale | 250,000 @ $6.78 | $1.7M | −3.3% of holding | −39.8% | −73.0% | 7,323,642 | Form 4 · filed 1 day after the trade |
| 2024-10-21 | Boxer Capital Management, LLC | other | Sale | 625,000 @ $7.05 | $4.4M | −7.6% of holding | −47.3% | −73.8% | 7,573,642 | Form 4 · filed 2 days after the trade |
| 2024-09-13 | Third Rock Ventures IV, L.P. | tenPercentOwner | Sale | 67,400 @ $10.53 | $710K | −0.4% of holding | −39.1% | −83.6% | 16,859,075 | Form 4 · filed 4 days after the trade |
| 2024-09-05 | Third Rock Ventures IV, L.P. | tenPercentOwner | Sale | 75,000 @ $11.56 | $867K | −0.4% of holding | −44.8% | −86.7% | 16,926,475 | Form 4 · filed 4 days after the trade |
| 2024-08-30 | Third Rock Ventures IV, L.P. | tenPercentOwner | Sale | 175,000 @ $11.60 | $2.0M | −1.0% of holding | −39.6% | −86.4% | 17,001,475 | Form 4 · filed 5 days after the trade |
| 2024-08-27 | Third Rock Ventures IV, L.P. | tenPercentOwner | Sale | 25,000 @ $11.55 | $289K | −0.1% of holding | −37.7% | −88.3% | 17,176,475 | Form 4 · filed 2 days after the trade |
| 2024-08-19 | Third Rock Ventures IV, L.P. | tenPercentOwner | Sale | 150,000 @ $10.09 | $1.5M | −0.9% of holding | −22.8% | −87.0% | 17,201,475 | Form 4 · filed 1 day after the trade |
| 2024-08-16 | Third Rock Ventures IV, L.P. | tenPercentOwner | Sale | 135,000 @ $9.79 | $1.3M | −0.8% of holding | −15.0% | −87.1% | 17,351,475 | Form 4 · filed 4 days after the trade |
| 2024-08-01 | Third Rock Ventures IV, L.P. | tenPercentOwner | Sale | 40,000 @ $9.80 | $392K | −0.2% of holding | +21.4% | −80.0% | 17,486,475 | Form 4 · filed same day |
| 2024-07-31 | Third Rock Ventures IV, L.P. | tenPercentOwner | Sale | 100,000 @ $9.93 | $993K | −0.6% of holding | +11.5% | −79.7% | 17,526,475 | Form 4 · filed 1 day after the trade |
| 2024-07-30 | Third Rock Ventures IV, L.P. | tenPercentOwner | Sale | 95,000 @ $9.80 | $931K | −0.5% of holding | +13.9% | −80.3% | 17,626,475 | Form 4 · filed 2 days after the trade |
| 2024-07-26 | Third Rock Ventures IV, L.P. | tenPercentOwner | Sale | 50,000 @ $9.84 | $492K | −0.3% of holding | +19.4% | −79.8% | 17,721,475 | Form 4 · filed 4 days after the trade |
| 2024-07-25 | Third Rock Ventures IV, L.P. | tenPercentOwner | Sale | 100,599 @ $9.87 | $993K | −0.6% of holding | +13.1% | −81.0% | 17,771,475 | Form 4 · filed 1 day after the trade |
| 2024-07-24 | Third Rock Ventures IV, L.P. | tenPercentOwner | Sale | 200,000 @ $9.82 | $2.0M | −1.1% of holding | +8.4% | −82.4% | 17,872,074 | Form 4 · filed 2 days after the trade |
| 2024-07-23 | Third Rock Ventures IV, L.P. | tenPercentOwner | Sale | 125,000 @ $9.79 | $1.2M | −0.7% of holding | +5.4% | −79.5% | 18,072,074 | Form 4 · filed 1 day after the trade |
| 2024-07-22 | Third Rock Ventures IV, L.P. | tenPercentOwner | Sale | 262,740 @ $9.78 | $2.6M | −1.4% of holding | +11.6% | −78.9% | 18,197,074 | Form 4 · filed 2 days after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
70 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-01 | Crystal Adam | officer | Option exercise | 27,000 | 142,743 | Form 4 |
| 2026-09-01 | Crystal Adam | officer | Option exercise | 27,000 | 260,040 | Form 4 |
| 2026-08-03 | Crystal Adam | officer | Option exercise | 27,000 | 142,743 | Form 4 |
| 2026-08-03 | Crystal Adam | officer | Option exercise | 27,000 | 287,040 | Form 4 |
| 2026-07-01 | Crystal Adam | officer | Option exercise | 27,000 | 142,743 | Form 4 |
| 2026-07-01 | Crystal Adam | officer | Option exercise | 27,000 | 314,040 | Form 4 |
| 2026-06-19 | Azelby Robert | director | Award / grant | 5,740 | 5,740 | Form 4 |
| 2026-06-19 | Azelby Robert | director | Award / grant | 35,910 | 35,910 | Form 4 |
| 2026-06-05 | Lee Sung | director | Award / grant | 3,570 | 3,570 | Form 4 |
| 2026-06-05 | Rothenberg Mace | director | Award / grant | 4,000 | 41,500 | Form 4 |
| 2026-06-05 | Rothenberg Mace | director | Award / grant | 25,000 | 25,000 | Form 4 |
| 2026-06-05 | Ketchum John B | director | Award / grant | 25,000 | 25,000 | Form 4 |
| 2026-06-05 | Lee Sung | director | Award / grant | 570 | 22,870 | Form 4 |
| 2026-06-05 | Ketchum John B | director | Award / grant | 4,000 | 24,937 | Form 4 |
| 2026-06-05 | Calhoun Lesley Ann | director | Award / grant | 25,000 | 25,000 | Form 4 |
| 2026-06-05 | Calhoun Lesley Ann | director | Award / grant | 4,000 | 16,500 | Form 4 |
| 2026-06-01 | Crystal Adam | officer | Option exercise | 27,000 | 142,743 | Form 4 |
| 2026-06-01 | Crystal Adam | officer | Option exercise | 27,000 | 341,040 | Form 4 |
| 2026-05-01 | Crystal Adam | officer | Option exercise | 27,000 | 142,743 | Form 4 |
| 2026-05-01 | Gall Matthew | officer | Award / grant | 240,000 | 240,000 | Form 4 |
| 2026-05-01 | Crystal Adam | officer | Option exercise | 27,000 | 368,040 | Form 4 |
| 2026-05-01 | Gall Matthew | officer | Award / grant | 40,000 | 40,000 | Form 4 |
| 2026-04-29 | Lee Sung | director | Award / grant | 12,300 | 22,300 | Form 4 |
| 2026-04-29 | Lee Sung | director | Award / grant | 5,200 | 5,200 | Form 4 |
| 2026-04-15 | Crystal Adam | officer | Option exercise | 38,460 | 151,082 | Form 4 |
| 2026-04-15 | Crystal Adam | officer | Option exercise | 38,460 | 395,040 | Form 4 |
| 2026-04-01 | Crystal Adam | officer | Option exercise | 27,000 | 139,622 | Form 4 |
| 2026-04-01 | Crystal Adam | officer | Option exercise | 27,000 | 433,500 | Form 4 |
| 2026-03-25 | Crystal Adam | officer | Option exercise | 12,000 | 124,622 | Form 4 |
| 2026-03-25 | Crystal Adam | officer | Option exercise | 12,000 | 460,500 | Form 4 |
| 2026-02-02 | Beckman Daniella | director | Award / grant | 265,980 | 265,980 | Form 4 |
| 2026-02-02 | Crystal Adam | officer | Award / grant | 47,460 | 205,670 | Form 4 |
| 2026-02-02 | Weber Barbara | director | Award / grant | 37,522 | 1,659,773 | Form 4 |
| 2026-02-02 | Crystal Adam | officer | Award / grant | 284,760 | 284,760 | Form 4 |
| 2026-02-02 | Beckman Daniella | director | Award / grant | 44,330 | 194,614 | Form 4 |
| 2026-02-02 | Weber Barbara | director | Award / grant | 222,132 | 222,132 | Form 4 |
| 2026-01-08 | Peters Malte | director | Award / grant | 1,650,000 | 1,650,000 | Form 4 |
| 2026-01-08 | Peters Malte | director | Award / grant | 350,000 | 367,500 | Form 4 |
| 2026-01-02 | Lee Sung | director | Award / grant | 60,000 | 60,000 | Form 4 |
| 2026-01-02 | Lee Sung | director | Award / grant | 10,000 | 10,000 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.